The treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomized trial of duloxetine versus placebo

被引：0

作者：

Gao, Yan ^{[1
]}

Guo, Xiaohui ^{[1
]}

Han, Ping ^{[2
]}

Li, Quanmin ^{[3
]}

Yang, Gangyi ^{[4
]}

Qu, Shen ^{[5
]}

Yue, Li ^{[6
]}

Wang, Chia-Ning ^{[6
]}

Skljarevski, Vladimir ^{[7
]}

Duenas, Hector ^{[8
]}

Raskin, Joel ^{[7
]}

Gu, Liqun ^{[6
]}

机构：

[1] Peking Univ, Hosp 1, Beijing 100871, Peoples R China

[2] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China

[3] Chinese Peoples Liberat Army, Artillery Gen Hosp 2, Beijing, Peoples R China

[4] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China

[5] Shanghai Tenth Peoples Hosp, Shanghai, Peoples R China

[6] Lilly Suzhou Pharmaceut Co Ltd, Shanghai Branch, Shanghai, Peoples R China

[7] Eli Lilly & Co, Indianapolis, IN 46285 USA

[8] Eli Lilly Mexico, Mexico City, DF, Mexico

来源：

DIABETES-METABOLISM RESEARCH AND REVIEWS | 2014年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

O221

引用

页码：30 / 31

页数：2

共 50 条

[1] Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo
Gao, Y.
Guo, X.
Han, P.
Li, Q.
Yang, G.
Qu, S.
Yue, L.
Wang, C. -N.
Skljarevski, V.
Duenas, H.
Raskin, J.
Gu, L.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (09) : 957 - 966
[2] A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of diabetic peripheral neuropathic pain
Raskin, J
Pritchett, YL
Wang, F
D'Souza, DN
Waninger, AL
Wernicke, JF
DIABETES, 2005, 54 : A126 - A126
[3] A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain
Raskin, J
Pritchett, YL
Wang, FJ
D'Souza, DN
Waninger, AL
Iyengar, S
Wernicke, JF
PAIN MEDICINE, 2005, 6 (05) : 346 - 356
[4] Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China
Gao Yan
Ning Guang
Jia Wei-ping
Zhou Zhi-guang
Xu Zhang-rong
Liu Zhi-min
Liu Chao
Ma Jian-hua
Li Qiang
Cheng Lu-lu
Wen Chong-yuan
Zhang Shu-yu
Zhang Qi
Desaiah, Durisala
Skljarevski, Vladimir
CHINESE MEDICAL JOURNAL, 2010, 123 (22) : 3184 - 3192
[5] Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China
Durisala Desaiah
Vladimir Skljarevski
中华医学杂志(英文版), 2010, (22) : 3184 - 3192
[6] Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China
Durisala Desaiah
Vladimir Skljarevski
CHINESE MEDICAL JOURNAL, 2010, (22)
[7] Comparative Efficacy of Duloxetine Versus Nortriptyline in Patients with Diabetic Peripheral Neuropathic Pain: A Double Blind Randomized Controlled Trial
Zakerkish, Mehrnoosh
Amiri, Fatemeh
Nasab, Nastaran Majdi
Ghorbani, Ali
IRANIAN RED CRESCENT MEDICAL JOURNAL, 2017, 19 (08)
[8] Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
Joharchi, Khojasteh
Memari, Moosareza
Azargashb, Eznollah
Saadat, Navid
JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2019, 18 (02) : 575 - 582
[9] Correction to: Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
Khojasteh Joharchi
Moosareza Memari
Eznollah Azargashb
Navid Saadat
Journal of Diabetes & Metabolic Disorders, 2019, 18 : 583 - 583
[10] Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, double-blind, noninferiority comparative study with pregabalin
Enomoto, Hiroyuki
Yasuda, Hitoshi
Nishiyori, Atsushi
Fujikoshi, Shinji
Furukawa, Masashi
Ishida, Mitsuhiro
Takahashi, Masashi
Tsuji, Toshinaga
Yoshikawa, Aki
Alev, Levent
JOURNAL OF PAIN RESEARCH, 2018, 11 : 1857 - 1868

← 1 2 3 4 5 →